Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor

BACKGROUND: The aim of this study was to investigate the efficacy and safety of anlotinib for patients with advanced non-small cell lung cancer (NSCLC) who progressed after standard regimens in real world situations and the preliminary analysis of an efficacy predictor. METHODS: A total of 118 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Jian-De, Chai, Li-Xun, Zhao, Zhi-Ping, Hao, Yan-Yan, Li, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367729/
https://www.ncbi.nlm.nih.gov/pubmed/32765067
http://dx.doi.org/10.2147/CMAR.S253366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367729/
https://www.ncbi.nlm.nih.gov/pubmed/32765067
http://dx.doi.org/10.2147/CMAR.S253366

Ejemplares similares